Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03367494 · ClinicalTrials.gov registry record · NA

A New Optical Sweat Test Method Based on a Citric Acid-derived Multi-halide Sensor

A NA study, sponsored by Milton S. Hershey Medical Center.

Terminated
Registry status
NA
Development phase
25
Enrollment target

NCT03367494 is a NA study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03367494, a NA study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.

TERMINATED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

Cystic Fibrosis (CF) is a hereditary multi-system disease affecting approximately 30,000n children and adults in the USA. The diagnosis of CF requires biochemical confirmation (either abnormal sweat chloride measurement and/or identification of two CF disease causing mutations) plus clinical symptomatology. Measurements of sweat chloride remain cumbersome and although most common methodology to confirm CF diagnosis with limitations especially in young children less than 6 months of age and in areas that lack ability for the complex testing. The study objectives of this current research proposal include: A) To expand upon previously obtained pilot study data "Evaluation of a fluorescent-based chloride sensor as an optical sweat test to diagnose cystic fibrosis" B) To add the exploratory measurement of sweat Bromide as a first in human assessment observation, C) To Evaluate the development of smartphone based point-of-care technology for chloride and bromide sensor measurements, D) To further expand the class of citrate-based sensors with improved fluorescence and sensing properties for the design of new fluorescence-based analytical and diagnostic solutions based on the automated multi-halide detection system, and E) To develop point-of-care systems that can successfully integrate into clinical settings to improve current practices and facilitate early detection of disease.

Interventions

  • DIAGNOSTIC_TEST Measurement of Sweat Chloride and Sweat Bromide

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2018-03-01
Est. Completion 2020-12-01
Phase NA

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT03367494

The ClinicalTrials.gov registry entry for NCT03367494 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Measurement of Sweat Chloride and Sweat Bromide is the first listed.

NCT03367494 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03367494 about?

NCT03367494 is a clinical study titled "A New Optical Sweat Test Method Based on a Citric Acid-derived Multi-halide Sensor". Cystic Fibrosis (CF) is a hereditary multi-system disease affecting approximately 30,000n children and adults in the USA. The diagnosis of CF requires biochemical confirmation (either abnormal sweat chloride measurement and/or identification of two CF disease causing mutations) plus clinical symptom...

What is the current status of trial NCT03367494?

This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2018-03-01. Estimated completion is 2020-12-01.

What interventions are being tested in trial NCT03367494?

The interventions under investigation include: Measurement of Sweat Chloride and Sweat Bromide (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03367494?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.